Wednesday Oct 8 | Business Wire
Abiomed to Showcase Impella(R) 2.5 Heart Recovery Device at TCT 2008
Abiomed Inc . today announced its schedule of events at the Cardiovascular Research Foundation's annual Transcatheter Cardiovascular Therapeutics scientific meeting, scheduled from October 13 to October 17, in ...
Abiomed, Inc. Confirms Revenue Guidance for Fiscal Year 2009
DANVERS, Mass. - Abiomed, Inc. today confirmed its fiscal year 2009 revenue guidance of $75 80 million.
Abiomed's Impella(R) 2.5 Device Now in 100 Leading U.S. Cardiac...
Daniel J. Sutherby, 978-777-5410 Chief Financial Officer ir@abiomed.com or Media Contact: Abiomed, Inc.
Abiomed Announces Preliminary Schedule of Events at TCT 2008
Abiomed Inc. , today announced its preliminary schedule of events at the Cardiovascular Research Foundation's annual Transcatheter Cardiovascular Therapeutics scientific meeting, scheduled from Sunday, October ...
Tiny Propeller in Heart May Save Lives
Kim Zeoli suffered her first heart attack shortly after turning 50 in 1991 and was hospitalized several times during the next 17 years -- including a quadruple bypass after a heart attack just a few months ...
Abiomed aims for $40M in follow-on stock sale
Medical device maker Abiomed Inc. is selling 2.4 million shares of common stock in a new offering.
TradingMarkets Monday Stock Movers: ABMD, EXAC, RCII
Stocks are under pressure one hour into trading on Monday, with the smaller stocks of the Nasdaq leading the market lower.
Analyst rates Abiomed stock "sell"
An analyst with SMH Capital has rated Abiomed Inc. stock as a "sell," after the company's stock price hit a high of $20 for the year.
Abiomed Inc. , a Danvers-based maker of cardiac devices, reports it has agreed to convert a $5 million loan it received from World Heart Corp.
Biotech incubator planned for North Shore
A group of North Shore biotech veterans is looking to capitalize on the Patrick administration's $1 billion incentive package by setting up a life sciences incubator in Beverly.
Public relations, press release distribution, investor relations, SEC filing
RadNet, Inc. , a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and - DANVERS, Mass.-- --ABIOMED, Inc.
Alcon Raises Guidance as Stock Soars
Alcon Inc. is a Switzerland developer of pharmaceuticals, surgical tools, contact lens care and other products for eye diseases and disorders.
Titan Machinery, Cyberonics and Abiomed among 52-week highs
Titan Machinery Inc , Cyberonics Inc and Abiomed Inc are among the new 52-week highs in Monday's trading among companies with market capitalizations under $1 billion.
Cautious Wall Street takes a step backward
Wall Street retreated Monday on more signs of economic weakness and executive shake-ups at two major banks -- reminders of the ongoing fallout from the credit crisis.
Abiomed Receives 510(k) Clearance from FDA for Impella 2.5 Device
World's Smallest Heart Pump Available to Doctors and Patients in the U.S. Abiomed, Inc.
FDA approves new, tiny heart pump
Medical technology company Abiomed Inc. has announced U.S. Food and Drug Administration approval of its Impella 2.5 Cardiac Assist Device heart pump.
Abiomed's to begin selling "world's smallest heart pump" in U.S.
Abiomed Inc. of Danvers said on Monday it received clearance to begin selling what it calls the world's smallest heart pump to U.S. cardiologists.
Advisory board named to dole out Bay State bio bucks
Mass High Tech: The Journal of New England Technology - by Catherine Williams Mass High Tech Alan Macdonald, executive director of the Massachusetts Business Roundtable, said the Massachusetts Life Sciences ...
Abiomed posts wider Q4 loss, guides fiscal '09 revenues below the Street
Medical device company Abiomed, Inc. reported a wider-than-expected loss for its fiscal fourth quarter of 2008 this morning.
St. Francis Hospital participates in unique heart recovery clinical trial
“We are please to participate in the pivotal PROTECT II trial and we look forward to improving the treatment of high-risk patients”
Heart attack patients and others with coronary conditions may benefit from a catheter-based pump device being evaluated in a clinical trial now under way at St. via Indianapolis Star